Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1974 Aug 31;3(5930):556–558. doi: 10.1136/bmj.3.5930.556

Oral Contraceptives and Increased Formation of Soluble Fibrin

L O Pilgeram, J Ellison, G Von Dem Bussche
PMCID: PMC1611535  PMID: 4414937

Abstract

Soluble fibrin was measured weekly for two months in 12 normal women and in 12 women on combined oestrogen-progestogen therapy (Ortho-Novin, Norinyl, Enavid, Ovral, Ovulen, Demulen). Plasma soluble fibrin concentration in women on oral contraceptives showed an increase of 97·2% (P <0·001) above that of normal women. In three cases, where each woman on the oral contraceptive served as her own control, stopping medication led to a return to normal of the plasma content of soluble fibrin.

Full text

PDF
556

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHATTERJEA J. B., SALOMON L. Antagonistic effect of A.C.T.H. and cortisone on the anticoagulant activity of ethyl biscoumacetate. Br Med J. 1954 Oct 2;2(4891):790–792. doi: 10.1136/bmj.2.4891.790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DE NICOLA P. Bemerkungen über die Indikationen und Kontraindikationen der Antikoagulantientherapie auf Grund der gerinnungsphysiologischen Ergebnisse. Schweiz Med Wochenschr. 1954 Jul 17;84(29):835–838. [PubMed] [Google Scholar]
  3. FAZLULLAH S. Thromboembolic complications during and after cortisone and ACTH therapy. Postgrad Med J. 1956 Sep;32(371):444–446. doi: 10.1136/pgmj.32.371.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FEARNLEY G. R. MEASUREMENT OF SPONTANEOUS FIBRINOLYTIC ACTIVITY. J Clin Pathol. 1964 May;17:307–309. doi: 10.1136/jcp.17.3.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kisker C. T., Rush R. Detection of intravascular coagulation. J Clin Invest. 1971 Nov;50(11):2235–2241. doi: 10.1172/JCI106720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. PILGERAM L. O., AMUNDSON B. A., LOFGREN P. E. EVIDENCE FOR STEROID CONTROL OF THE METABOLISM OF PROFIBRINOLYSIN. Thromb Diath Haemorrh. 1964 Apr 15;11:94–98. [PubMed] [Google Scholar]
  7. PILGERAM L. O. BLOOD COAGULABILITY AND ORAL CONTRACEPTION. Br Med J. 1964 Apr 4;1(5387):883–884. doi: 10.1136/bmj.1.5387.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. PILGERAM L. O. Relation of plasma fibrinogen concentration changes to human arteriosclerosis. J Appl Physiol. 1961 Jul;16:660–664. doi: 10.1152/jappl.1961.16.4.660. [DOI] [PubMed] [Google Scholar]
  9. PROCTOR R. R., RAPAPORT S. I. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol. 1961 Sep;36:212–219. doi: 10.1093/ajcp/36.3.212. [DOI] [PubMed] [Google Scholar]
  10. Pilgeram L. O., Chee A. N., Von dem Bussche G. Evidence for abnormalities in clotting and thrombolysis as a risk factor for stroke. Stroke. 1973 Jul-Aug;4(4):643–657. doi: 10.1161/01.str.4.4.643. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES